High-mobility group box 1 (HMGB1) is a DNA-binding protein abundantly expressed in the nucleus that has gained much attention for its regulation of immunity and inflammation. Despite this, whether and how HMGB1 contributes to protective and/or pathological responses in vivo is unclear. In this study, we constructed Hmgb1-floxed (Hmgb1 f/f ) mice to achieve the conditional inactivation of the gene in a cell-and tissue-specific manner by crossing these mice with an appropriate Cre recombinase transgenic strain. Interestingly, although mice with HMGB1 ablation in myeloid cells apparently develop normally, they are more sensitive to endotoxin shock compared with control mice, which is accompanied by massive macrophage cell death. Furthermore, these mice also show an increased sensitivity to Listeria monocytogenes infection. We also provide evidence that the loss of HMGB1 in macrophages results in the suppression of autophagy, which is commonly induced by lipopolysaccharide stimulation or L. monocytogenes infection. Thus, intracellular HMGB1 contributes to the protection of mice from endotoxemia and bacterial infection by mediating autophagy in macrophages. These newly generated HMGB1 conditional knockout mice will serve a useful tool with which to study further the in vivo role of this protein in various pathological conditions. LPS | IL-1β | IL-18
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O f the four members of the high-mobility group box (HMGB) family, HMGB1 is the best studied, given its versatile functions in various aspects of cellular responses (1) (2) (3) (4) (5) . Ubiquitously expressed in all cells, HMGB1 is found en masse in the nucleus and is supposedly released into the extracellular fluid through an endoplasmic reticulum-Golgi pathway-independent mechanism from immune cells such as monocytes or macrophages after stimulation with lipopolysaccharide (LPS), proinflammatory cytokines, or nitric oxide (1, 6) . The release of HMGB1 is also regulated by the inflammasome, a multiprotein oligomer that activates caspase-1 to promote the maturation of inflammatory cytokines, interleukin-1β (IL-1β) and IL-18, and by dying cells, typically those undergoing necrosis (7) (8) (9) (10) . Secreted or released, HMGB1 is known to participate in the activation of cell surface innate immune receptors, typically Toll-like receptors (TLRs), thereby affecting many aspects of the host's inflammatory responses upon infection or noxious stresses (1) (2) (3) (4) (5) . Perhaps most notably is the crucial role of HMGB1 in LPS-induced endotoxemia, whereby administration of an anti-HMGB1 antibody significantly protects mice from lethality (1, 11) . The study of released HMGB1 is complicated by a number of complex posttranslational modifications made to the protein, including acetylation and redox modifications that may regulate HMGB1 function (12) (13) (14) .
HMGB1 can regulate immune reactions in several ways. Cytosolic HMGB1, together with the other members of the family, function as universal sentinels or chaperones for immunogenic nucleic acids by facilitating the recognition of nucleic acids by more discriminative, nucleic acid-sensing innate receptors (15) (16) (17) . In addition, HMGB1 regulates autophagy, a cellular response that functions in clearing long-lived proteins and dysfunctional organelles to generate substrates for adenosine triphosphate (ATP) production during periods of starvation and other types of cellular stress events (13, (18) (19) (20) . This mechanism contributes to antimicrobial responses against invading microorganisms (21, 22) . Indeed, microorganisms can induce autophagy by stimulating innate immune receptors, such as TLRs, by a process in which bacteria are captured by phagocytosis but remain within intact vacuoles, an autophagic process termed microtubule-associated protein light chain 3 (LC3)-associated phagocytosis (LAP), which promotes the maturation of autophagosomes into autolysosomes (23, 24) .
Collectively, these studies place HMGB1 in the center of immunological events where it uniquely functions intracellularly and extracellularly as a mediator of immune and inflammatory responses. The biological and clinical importance of HMGB1 is underscored by the dysregulation of this protein in a number of pathological conditions, including sepsis, ischemia-reperfusion injury, arthritis, and cancer (1, (3) (4) (5) . Nonetheless, in vivo validation of the versatile functions described above is lacking due to the lethality of the Hmgb1-deficient mice, thought to cause lethal hypoglycemia in newborn mice (25) . In the present study, we describe the generation of Hmgb1-floxed (Hmgb1 f/f ) mice that
Significance
The high-mobility group box 1 (HMGB1) protein is abundantly expressed in the nucleus where it regulates chromatin function. More recently, it was found to also function in the cytoplasm and extracellular milieu for the regulation of immunity and inflammation. However, the in vivo study of HMGB1 has been hampered by the fact that HMGB1-deficient mice die soon after birth. In this study, we successfully generated Hmgb1-floxed mice to achieve conditional inactivation of the gene in a cell-and tissue-specific manner. We demonstrate that cytosolic HMGB1 in myeloid cells is critical for the protection of the host from endotoxemia and bacterial infection by inducing autophagy, a cellular response critical for maintaining cellular viability in the setting of various stresses including infection.
enabled the cell-and tissue-specific deletion of the gene when crossed with an appropriate Cre recombinase transgenic strain. We demonstrate in this study a protective role of intracellular HMGB1 in macrophages where it serves as a crucial regulator of autophagosome formation in the context of LPS stimulation or bacterial infection in vivo. Finally, we will discuss the future prospects of HMGB1 research using these newly generated mutant mice.
Results

Generation of Hmgb1
f/f Mice. To study the function of HMGB1 in distinct cells and tissues, we generated mice with a conditional knockout of the Hmgb1 gene by using the Cre-loxP system. As depicted in Fig. S1A , the targeting vector was constructed to cause the deletion of exons 2-4 upon expression of Cre protein.
A neomycin resistance (neo) gene flanked by two loxP sites was introduced into intron 1 of the gene, whereas a third loxP site was generated downstream of exon 4. Mouse embryonic stem cells (ES) were electroporated with this vector, selected in the presence of G418 and then homologous recombinant clones identified by PCR and confirmed by Southern blot analysis (Fig.  S1B) . Cre protein was then transiently expressed in the targeted ES clones to delete the loxP-flanked neo gene (Fig. S1C) . The resulting ES clones, carrying the loxP-flanked (floxed) Hmgb1 gene, were used to generate chimeric mice that successfully transmitted the gene in the germ line. Mice homozygous for the floxed Hmgb1 gene (Hmgb1 f/f ) were born at the expected Mendelian ratios and presented with no obvious abnormalities. When these mice were crossed with mice transgenic for a CAG promoter-driven cre gene in which cre recombinase expression is constitutively and broadly driven by the cytomegalovirus early enhancer element and chicken β-actin promoter (26), mice died soon after birth, which is consistent with a previous report (25) (Fig. S2) . ) were born and developed normally. As shown in Fig. 1A , HMGB1 expression was barely detectable in peritoneal macrophages of these mice, whereas HMGB1 was expressed normally in other cells such as T and B lymphocytes (Fig. S3A ). We further examined myeloid cell populations in the peritoneal cavity, spleen, blood, and bone marrow of these mice. As shown in Fig. 1B , no overt difference was found in the cellularity of the myeloid lineage, indicating that the loss of HMGB1 does not affect the development of these cells. Further, we observed no difference in the in vitro differentiation of M1 or M2 macrophages in LysM
Cre/+ -Hmgb1 f/f mice (Fig. S3B ).
Susceptibility of LysM
Cre/+ -Hmgb1 f/f Mice to LPS-Induced Endotoxemia.
There has been a particular focus on HMGB1 in the context of LPS-induced endotoxemia, wherein HMGB1 released by myeloid cells is reported to be capable of activating various innate receptors, especially TLR4, and thereby exacerbating pathogenic inflammatory responses (11, 27) . We therefore first examined whether and how LysM Cre/+ -Hmgb1 f/f mice respond to LPS. We observed that LysM
Cre/+ -Hmgb1 f/f mice were more vulnerable to i.p. injection of LPS and were accompanied by a massive amount of tissue destruction in the lungs compared with LysM +/+ -Hmgb1 f/f mice ( Fig. 2A ). This observation indicates there is a protective role of HMGB1, which seemingly contrasts with the prevailing notion that it exacerbates endotoxemia (1, 2, 11).
We then examined serum levels of proinflammatory cytokines thought to participate in the pathogenic response to LPS and found that levels of TNF-α, IL-6, and IL-12p40 in LysM
mice were similar to those found in LysM 2B) . Interestingly, however, there was a notable increase of IL-1β and IL-18 in the serum of the LysM
f/f mice, indicating a hyperactivation of an inflammasome pathway(s) (Fig. 2C) . In this experimental setting, serum HMGB1 levels were only marginally lower compared with those of LysM +/+ -Hmgb1 f/f mice (Fig. 2D) , demonstrating that myeloid cells are not the main source of LPS-induced serum HMGB1 and that the increased vulnerability to LPS reflects a function of intracellular HMGB1 vis-à-vis extracellular HMGB1.
The elevated IL-1β and IL-18 expression in the serum of the LPS-stimulated LysM production, a hallmark of inflammasome activation. As shown in Fig. 2E , a marked increase of both IL-1β and IL-18 was observed in the LysM Cre/+ -Hmgb1 f/f macrophages. In view of a previous report showing that caspase-1-deficient mice are highly resistant to LPS-induced endotoxemia (28), our observation indicates that intracellular HMGB1 in macrophages functions as a negative regulator of the inflammasome activation pathway, which may account for our observed LPS sensitivity in the LysM
Critical Contribution of HMGB1 at the Interface Between Autophagy and Cell Death. It has been shown that the inflammasome pathway is regulated by autophagy which, as described above, has multiple immunological functions and influences immune responses to infection (13, 18, 19, (21) (22) (23) . Because LPS can activate autophagy through the TLR4/Toll/IL-1 receptor domain-containing adapterinducing interferon-β (TRIF)/p38 MAPK signaling pathway and autophagic proteins regulate caspase-1-mediated innate immune responses (29-31), we wished to examine whether enhanced inflammasome activation in the absence of HMGB1 (Fig. 2E) is a consequence of an unregulated autophagic process. We examined the status of microtubule-associated protein light chain 3 (LC3), a well-known marker of autophagosomes (32) . As shown in Fig. 3A , LPS stimulation of LysM
Cre/+ -Hmgb1 f/f macrophages resulted in a significant decrease in the formation of two cleaved forms of LC3, LC3-I and LC3-II, which typically represent the induction of autophagosomes (32, 33) , compared with LysM
f/f macrophages. These data indicate that HMGB1 is required for the autophagic process.
We also examined the in vivo regulation of macrophage fate following LPS administration in these mice. As shown in Fig.  3B , we observed a marked decrease of macrophage populations in LysM
Cre/+ -Hmgb1 f/f mice compared with LysM +/+ -Hmgb1
mice. Because suppression of autophagy results in cell death, this observation is consistent with the above in vitro results. Although TLR4 stimulation alone cannot induce cell death, it can if the pan-caspase inhibitor z-VAD-fmk is present (34, 35) . Under this in vitro experimental setting, a marked enhancement of macrophage cell death was observed in the absence of HMGB1 (Fig. 3C) . Thus, these observations in toto indicate that HMGB1 critically regulates autophagy and cell death in macrophages following TLR4 activation. Because autophagy functions in a wide variety of cell types, we asked whether this observation can also be made in dendritic cells or hepatocytes, by respectively expressing the cre recombinase gene under the promoter of CD11c or albumin (Cd11c
f/f mice). In both cases, we observed a phenotype similar to that seen in LysM
f/f mice, namely, an elevation of serum IL-1β and IL-18 upon LPS stimulation, but no change in serum TNF-α, IL-6, or IL-12p40 levels ( Fig. S4 A and B) . Thus, HMGB1-mediated autophagy is likely to be a cell-typeindependent mechanism.
Requirement of Macrophage HMGB1 in Antibacterial Responses. Because autophagy also participates in the host's response against infection by various pathogens, particularly the clearance of intracellular bacteria, we next examined LysM Cre/+ -Hmgb1 f/f mice in response to a pathogenic bacterium Listeria monocytogenes. As shown in Fig. 4A , these mice showed a marked vulnerability to the bacterial infection compared with LysM +/+ -Hmgb1 f/f mice. Expectedly, there was a marked elevation of bacterial burden seen in the spleen and liver of LysM Cre/+ -Hmgb1 f/f mice (Fig. 4B) , although mRNA levels of inflammatory cytokines remained essentially unchanged (Fig. S5) .
Interestingly, the generation of LC3-II was significantly suppressed in peritoneal macrophages of infected LysM 
LysM
Cre/+ -Hmgb1 a critical role for HMGB1 in bacteria-induced autophagy in these cells (Fig. 4C) . We also observed that upon bacterial infection of macrophages in vitro, there was a noticeable accumulation of HMGB1 in the cytosol, which also occurs upon LPS stimulation (36, 37) (Fig. 4D ). Of note, cytosolic HMGB1 merged with bacterial DNA, suggesting an association of this protein with 
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Merge autophagosomes for autophagy-mediated bacterial eradication (Fig. 4D) . Collectively, these results support the notion that HMGB1, released from the nucleus to the cytosol upon infection, participates in bacteria-induced autophagy, given that the absence of this protein severely affects bacterial clearance.
Discussion
In this study, we generated conditional knockout mice of HMGB1 to gain insight into its biological roles, specifically as it relates to immune responses, of this protein in vivo. These conditional knockout mice permitted the ablation of HMGB1 in a tissue-and cell-type-specific manner. Before our study, HMGB1 was identified as a multifunctional mediator of immune and inflammatory responses by virture of its role as danger-associated molecular patterns (DAMPs) or alarmins upon its release from the cell, which occurs typically by cell death or a still poorly characterized mechanism (1) (2) (3) (4) (5) . Intracellular HMGB1 is also an immune regulator, particularly in the cytoplasm where it functions as sensor and/or chaperone for immunogenic nucleic acids and mediates autophagy (13, 15, 17, 20) . This study illustrates the in vivo validation of HMGB1 in myeloid cells, showing its protective role in the cytoplasm against LPS-induced endotoxemia and infection by L. monocytogenes.
Interestingly, previous studies have shown that HMGB1 functions as a crucial instigator of LPS-induced endotoxemia (1, 2, 11). Our present study by no means excludes this pathological aspect of HMGB1. However, we demonstrate that cells of myeloid lineage are not the main source of proinflammatory HMGB1, as serum HMGB1 levels, induced by LPS, were only marginally affected in LysM
f/f mice (Fig. 2D) . Thus, it will be of great interest to clarify which cells are responsible for the proinflammatory HMGB1 as well as how it instigates inflammatory responses. In a similar context, the inflammatory function of hepatocyte-derived HMGB1 has been reported in ischemia-reperfusion injury. We therefore examined Alb
f/f mice but basically did not observe any overt differences compared with HMGB1-intact mice, suggesting that the hepatocyte-derived HMGB1 plays little, if any, role in this inflammatory pathogenesis (Fig. S6) . Thus, the role and source of HMGB1 in this ischemia-reperfusion injury model also needs further clarification.
The antimicrobial functions of autophagy are known to serve as a series of barriers against invading microorganisms, wherein the antimicrobial function of LAP, which involves the engagement of the autophagic machinery while the bacterium is confined in the nascent and presumably intact phagosome, is well characterized. Our results indicate a critical role of HMGB1 in this process as revealed by an increased vulnerability to L. monocytogenes infection and the suppression of LC3-II generation in macrophages, the hallmark of LAP (Fig. 4C) . Thus, this study reveals a unique, antibacterial function of HMGB1.
Our study also corroborates other reports that indicate the involvement of HMGB1 in the autophagic process (13, 20) . It has been reported that stimuli that enhance reactive oxygen species promote cytosolic translocation of HMGB1 from the nucleus where it directly interacts with the autophagy-related (ATG) protein Beclin-1, a Bcl-2-homology (BH)-3 domain-only protein that is essential for autophagy induction (13, 20) . Whether and/or how the suppression of autophagy in the absence of HMGB1 upon LPS stimulation or bacterial infection, revealed in this study, integrates to Beclin-1 and/or other molecules involved in autophagy remains to be determined further.
In summary, this study offers in vivo evidence for the protective aspect of cytosolic HMGB1 against endotoxemia and bacterial infection. The availability of the mice for conditional ablation of HMGB1 will provide new avenues of research for the investigation of this protein, which apparently shuttles from nucleus to cytoplasm to the extracellular environment. In particular, in view of the fact that the main source of serum HMGB1 upon LPS stimulation is not cells of myeloid cell lineage, further investigation by generation of additional Cre-loxP mutant mice will be an aide in the examination of the function of extracellular HMGB1 during endotoxemia.
It has been conventional wisdom that effector molecules are newly synthesized and released during immune or inflammatory responses typically starting at the level of transcriptional activation of the corresponding genes (23, 38, 39) . The present findings together with previous reports may point to the existence of an additional mechanism, that is, the nucleus, wherein HMGB1 is abundantly accumulated without cellular stimulation, functions as "arsenal" for this and other effector molecules to be released into the cytosol and extracellular milieu so as to ensure prompt and effective cellular responses. Indeed, the newly generated Hmgb1 f/f mice will allow further investigation to fully identify HMGB1's multiple functions during homeostasis and pathogenesis.
Materials and Methods
Mice. C57BL/6 mice were purchased from CLEA Japan, Inc. LysM-Cre knockin mice, Alb-Cre transgenic mice, CAG-Cre transgenic mice, and Cd11c-Cre transgenic mice were obtained from The Jackson Laboratory. All animal care and experiments conformed to the guidelines for animal experiments of the University of Tokyo, and were approved by the animal research committee of the University of Tokyo.
Construction of the Targeting Vector. A targeting vector was constructed to delete exons 2-4, which includes the translation initiation site of the Hmgb1 gene. Hmgb1 genomic DNA was amplified by PCR by using specific primers as follows: sense, 5′-actagtgcttgtctgtttcacagttttcgttac-3′ and antisense, 5′-gtcgacagttatcaagtataatcccctaacactgg-3′. The fragment was inserted between two loxP sites of the vector pKSTKNEOloxP, which has herpes simplex virus thymidine kinase and loxP-flanked pGK-neo. Then the 10.7-kb genomic fragment 5′ upstream of exon 2-4 and 3′ downstream 5-kb genomic fragment was inserted.
Reagents and Cells. LPS O55:B4 was purchased from Sigma. Ultrapure LPS and ATP were purchased from InvivoGen. z-VAD-fmk was purchased from Sigma. The mouse macrophage cell line RAW264.7 cells were cultured and maintained as described (13, 15, 17, 20) . For preparing peritoneal macrophages, mice were injected with 2 mL of 4% (wt/vol) thioglycollate solution intraperitoneally. The peritoneal cavity was washed by PBS, containing 2% (vol/vol) FCS and 1 mM EDTA to collect peritoneal exudate cells 4 d after the injection, and cells were plated on Petri dishes for 2 h in RPMI, supplemented with 10% (vol/vol) FCS. After incubation, cells were recollected and seeded for each assay. Bone marrow cells were extracted from each mouse as described previously (17, 40) , then seeded in 15-cm cell culture dishes and cultured in RPMI supplemented with 10% (vol/vol) FCS and M-CSF (100 ng/mL; Peprotech) for 6 d. M-CSF cultured bone-marrow-derived macrophages (BMMs) were replated for each assay. CD3e
+ T cells and CD19 + B cells were prepared by using a CD3e
MicroBead kit (Miltenyi Biotec) and a CD19 MicroBead kit (Miltenyi Biotec), respectively, according to the manufacturer's protocol.
LPS-Induced Lethal Shock. Mice were injected intraperitoneally with LPS (17.5 mg/kg weight) and monitored every 12 h. Whole blood samples were taken sequentially from tails, and sera were prepared by centrifugation for 5 min at 4°C at 8,000 × g after incubation at room temperature for 30 min. For plasma sample preparation, blood samples were treated with 5 mM EDTA.
Statistical Analysis. Differences between control and experimental groups were evaluated with a Student t test. Additional information can be found in SI Materials and Methods.
